Global Erectile Dysfunction Drugs Market Research Report 2025

Publication ID:

PB504255483

Publication Date:

April 16, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Erectile Dysfunction Drugs was valued at US$ 5450 million in the year 2024 and is projected to reach a revised size of US$ 8149 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.
The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erectile Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Erectile Dysfunction Drugs Market Overview
1.1 Product Definition
1.2 Erectile Dysfunction Drugs by Type
1.2.1 Global Erectile Dysfunction Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs by Application
1.3.1 Global Erectile Dysfunction Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Drugs Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Drugs Revenue 2020-2031
1.4.2 Global Erectile Dysfunction Drugs Sales 2020-2031
1.4.3 Global Erectile Dysfunction Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Drugs Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Erectile Dysfunction Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Erectile Dysfunction Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction Drugs, Product Type & Application
2.7 Global Key Manufacturers of Erectile Dysfunction Drugs, Date of Enter into This Industry
2.8 Global Erectile Dysfunction Drugs Market Competitive Situation and Trends
2.8.1 Global Erectile Dysfunction Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Erectile Dysfunction Drugs Players Market Share by Revenue
2.8.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Erectile Dysfunction Drugs Market Scenario by Region
3.1 Global Erectile Dysfunction Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Erectile Dysfunction Drugs Sales by Region: 2020-2031
3.2.1 Global Erectile Dysfunction Drugs Sales by Region: 2020-2025
3.2.2 Global Erectile Dysfunction Drugs Sales by Region: 2026-2031
3.3 Global Erectile Dysfunction Drugs Revenue by Region: 2020-2031
3.3.1 Global Erectile Dysfunction Drugs Revenue by Region: 2020-2025
3.3.2 Global Erectile Dysfunction Drugs Revenue by Region: 2026-2031
3.4 North America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.4.3 North America Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Erectile Dysfunction Drugs Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.5.3 Europe Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Erectile Dysfunction Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Erectile Dysfunction Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.7.3 Latin America Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Drugs Sales by Type (2020-2031)
4.1.1 Global Erectile Dysfunction Drugs Sales by Type (2020-2025)
4.1.2 Global Erectile Dysfunction Drugs Sales by Type (2026-2031)
4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2020-2031)
4.2 Global Erectile Dysfunction Drugs Revenue by Type (2020-2031)
4.2.1 Global Erectile Dysfunction Drugs Revenue by Type (2020-2025)
4.2.2 Global Erectile Dysfunction Drugs Revenue by Type (2026-2031)
4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Erectile Dysfunction Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Erectile Dysfunction Drugs Sales by Application (2020-2031)
5.1.1 Global Erectile Dysfunction Drugs Sales by Application (2020-2025)
5.1.2 Global Erectile Dysfunction Drugs Sales by Application (2026-2031)
5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2020-2031)
5.2 Global Erectile Dysfunction Drugs Revenue by Application (2020-2031)
5.2.1 Global Erectile Dysfunction Drugs Revenue by Application (2020-2025)
5.2.2 Global Erectile Dysfunction Drugs Revenue by Application (2026-2031)
5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Erectile Dysfunction Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Erectile Dysfunction Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Erectile Dysfunction Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Erectile Dysfunction Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Company Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Company Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Company Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharma Erectile Dysfunction Drugs Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.7.1 Dong-A ST Company Information
6.7.2 Dong-A ST Description and Business Overview
6.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dong-A ST Erectile Dysfunction Drugs Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Company Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Company Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Company Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CSBIO. Erectile Dysfunction Drugs Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Drugs Industry Chain Analysis
7.2 Erectile Dysfunction Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Drugs Production Mode & Process Analysis
7.4 Erectile Dysfunction Drugs Sales and Marketing
7.4.1 Erectile Dysfunction Drugs Sales Channels
7.4.2 Erectile Dysfunction Drugs Distributors
7.5 Erectile Dysfunction Drugs Customer Analysis
8 Erectile Dysfunction Drugs Market Dynamics
8.1 Erectile Dysfunction Drugs Industry Trends
8.2 Erectile Dysfunction Drugs Market Drivers
8.3 Erectile Dysfunction Drugs Market Challenges
8.4 Erectile Dysfunction Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂